The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy
Open accessAbstract
Peripheral neuropathy is a severe dose limiting toxicity associated with cancer chemotherapy. Ever since it was identified, the clear pathological mechanisms underlying chemotherapy induced peripheral neuropathy (CIPN) remain sparse and considerable involvement of oxidative stress and neuroinflammation has been realized recently. Despite the empirical use of antioxidants in the therapy of CIPN, the oxidative stress mediated neuronal damage in peripheral neuropathy is still debatable. The current review focuses on nerve damage due to oxidative stress and mitochondrial dysfunction as key pathogenic mechanisms involved in CIPN. Oxidative stress as a central mediator of apoptosis, neuroinflammation, metabolic disturbances and bioenergetic failure in neurons has been highlighted in this review along with a summary of research on dietary antioxidants and other nutraceuticals which have undergone prospective controlled clinical trials in patients undergoing chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemotherapy-Associated Oxidative Stress: Impact on Chemotherapeutic Effectiveness
Conklin, K. A. (2004) · Integrative Cancer Therapies · doi:10.1177/1534735404270335 · Cited by 752
Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
Wolf, S., Barton, D., Kottschade, L., Grothey, A., & Loprinzi, C. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.04.018 · Cited by 632
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
Argyriou, A. A., Bruna, J., Marmiroli, P., & Cavaletti, G. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.04.012 · Cited by 568
Flatters, S. J. L., & Bennett, G. J. (2006) · Pain · doi:10.1016/j.pain.2006.01.037 · Cited by 535
Smith, R. A. J., Hartley, R. C., Cochemé, H. M., & Murphy, M. P. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.010 · Cited by 499
The Roles of Oxidative Stress and Antioxidant Treatment in Experimental Diabetic Neuropathy
Low, P. A., Nickander, K. K., & Tritschler, H. J. (1997) · Diabetes · doi:10.2337/diab.46.2.s38 · Cited by 432
Cascinu, S., Catalano, V., Cordella, L., Labianca, R., Giordani, P., Baldelli, A. M., Beretta, G. D., Ubiali, E., & Catalano, G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.061 · Cited by 421
Ganesh Yerra, V., Negi, G., Sharma, S. S., & Kumar, A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.07.005 · Cited by 412
Self-citationAutophagy as an essential cellular antioxidant pathway in neurodegenerative disease
Giordano, S., Darley-Usmar, V., & Zhang, J. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.013 · Cited by 366
Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy
Jaggi, A. S., & Singh, N. (2012) · Toxicology · doi:10.1016/j.tox.2011.10.019 · Cited by 358
A review on oxaliplatin-induced peripheral nerve damage
Argyriou, A. A., Polychronopoulos, P., Iconomou, G., Chroni, E., & Kalofonos, H. P. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.01.003 · Cited by 330
Peripheral Neuropathy Induced by Paclitaxel: Recent Insights and Future Perspectives
Scripture, C., Figg, W., & Sparreboom, A. (2006) · Current Neuropharmacology · doi:10.2174/157015906776359568 · Cited by 320
Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neurons
Podratz, J. L., Knight, A. M., Ta, L. E., Staff, N. P., Gass, J. M., Genelin, K., Schlattau, A., Lathroum, L., & Windebank, A. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.11.017 · Cited by 320
Negi, G., Kumar, A., & Sharma, S. S. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00821.x · Cited by 314
Self-citationHawkes, A. L., Hamilton, K., White, K. M., & Young, R. M. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-1 · Cited by 313
Neuroprotective Effect of Vitamin E Supplementation in Patients Treated With Cisplatin Chemotherapy
Pace, A., Savarese, A., Picardo, M., Maresca, V., Pacetti, U., Del Monte, G., Biroccio, A., Leonetti, C., Jandolo, B., Cognetti, F., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.139 · Cited by 307
Roles of reactive oxygen and nitrogen species in pain
Salvemini, D., Little, J. W., Doyle, T., & Neumann, W. L. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.026 · Cited by 295
Cavaletti, G., Frigeni, B., Lanzani, F., Mattavelli, L., Susani, E., Alberti, P., Cortinovis, D., & Bidoli, P. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.008 · Cited by 274
Zheng, H., Xiao, W. H., & Bennett, G. J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.016 · Cited by 272
Antioxidants in Central Nervous System Diseases: Preclinical Promise and Translational Challenges
Kamat, C. D., Gadal, S., Mhatre, M., Williamson, K. S., Pye, Q. N., & Hensley, K. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-15314 · Cited by 237
Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy
Wang, X.-M., Lehky, T. J., Brell, J. M., & Dorsey, S. G. (2012) · Cytokine · doi:10.1016/j.cyto.2012.03.027 · Cited by 220
Wang, W.-S., Lin, J.-K., Lin, T.-C., Chen, W.-S., Jiang, J.-K., Wang, H.-S., Chiou, T.-J., Liu, J.-H., Yen, C.-C., & Chen, P.-M. (2007) · The Oncologist · doi:10.1634/theoncologist.12-3-312 · Cited by 210
Melli, G., Taiana, M., Camozzi, F., Triolo, D., Podini, P., Quattrini, A., Taroni, F., & Lauria, G. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.08.013 · Cited by 202
Vitamin E neuroprotection for cisplatin neuropathy: A randomized, placebo-controlled trial
Pace, A., Giannarelli, D., Galiè, E., Savarese, A., Carpano, S., Della Giulia, M., Pozzi, A., Silvani, A., Gaviani, P., Scaioli, V., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d5279e · Cited by 191
Xiao, W. H., & Bennett, G. J. (2012) · Pain · doi:10.1016/j.pain.2011.12.011 · Cited by 191
Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy
Zheng, H., Xiao, W. H., & Bennett, G. J. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.08.023 · Cited by 184
Negi, G., Kumar, A., & S. Sharma, S. (2011) · Current Neurovascular Research · doi:10.2174/156720211798120972 · Cited by 183
Self-citationSmyth, J. F., Bowman, A., Perren, T., Wilkinson, P., Prescott, R. J., Quinn, K. J., & Tedeschi, M. (1997) · Annals of Oncology · doi:10.1023/a:1008211226339 · Cited by 178
Xiao, W. H., Zheng, H., Zheng, F. Y., Nuydens, R., Meert, T. F., & Bennett, G. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.010 · Cited by 175
Kottschade, L. A., Sloan, J. A., Mazurczak, M. A., Johnson, D. B., Murphy, B. P., Rowland, K. M., Smith, D. A., Berg, A. R., Stella, P. J., & Loprinzi, C. L. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-010-1018-3 · Cited by 173
Ghoreishi, Z., Esfahani, A., Djazayeri, A., Djalali, M., Golestan, B., Ayromlou, H., Hashemzade, S., Asghari Jafarabadi, M., Montazeri, V., Keshavarz, S. A., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-355 · Cited by 171
Jin, H. W., Flatters, S. J. L., Xiao, W. H., Mulhern, H. L., & Bennett, G. J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.001 · Cited by 167
Bianchi, G., Vitali, G., Caraceni, A. T., Ravaglia, S., Capri, G., Cundari, S., Zanna, C., & Gianni, L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.028 · Cited by 152
Negi, G., Kumar, A., Joshi, R. P., & Sharma, S. S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.087 · Cited by 144
Self-citationJanes, K., Doyle, T. M., Bryant, L., Esposito, E., Cuzzocrea, S., Ryerse, J. S., Bennett, G. J., & Salvemini, D. (2013) · Pain · doi:10.1016/j.pain.2013.07.032 · Cited by 142
McDonald, E. S., & Windebank, A. J. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0468 · Cited by 135
Lin, P., Lee, M.-Y., Wang, W.-S., Yen, C., Chao, T., Hsiao, L., Yang, M., Chen, P., Lin, K., & Chiou, T.-J. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0018-9 · Cited by 112
Prasad, S. N., & ., M. (2013) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2013.10.003 · Cited by 91
Lupachyk, S., Shevalye, H., Maksimchyk, Y., Drel, V. R., & Obrosova, I. G. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.037 · Cited by 82
Ta, L. E., Schmelzer, J. D., Bieber, A. J., Loprinzi, C. L., Sieck, G. C., Brederson, J., Low, P. A., & Windebank, A. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054161 · Cited by 53
Melatonin, a Promising Role in Taxane-Related Neuropathy
Nahleh, Z. A., Pruemer, J. M., LaFollette, J. A., & Sweany, S. (2010) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s4132 · Cited by 42
Cited by
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
Zajączkowska, R., Kocot-Kępska, M., Leppert, W., Wrzosek, A., Mika, J., & Wordliczek, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061451 · Cited by 829
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
Starobova, H., & Vetter, I. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00174 · Cited by 648
Romani, A. M. P. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115323 · Cited by 383
From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation
Bajic, J. E., Johnston, I. N., Howarth, G. S., & Hutchinson, M. R. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00104 · Cited by 100
Metadata
- Authors
- Areti, A., Yerra, V. G., Naidu, V., & Kumar, A.
- Venue
- Redox Biology
- Publisher
- Elsevier BV
- Published
- 2014
- Volume
- 2
- Pages
- 289-295
- ISSN
- 2213-2317 (ISSN-L)
- OpenAlex
- W2149068355
- Cited by
- 456
- References
- 41
- FWCI
- 9.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.